Albion VC led the Series A round to support nationwide clinic expansion and international growth.
"The healthcare supply-demand gap remains a major challenge, with over 390,000 people waiting for treatable MSK care in England alone. Finn, Ric and the team have proven that autonomous care pathways can deliver strong outcomes at scale. They’ve earned NHS trust, navigated complex regulations, and built a service that improves access to care. Having proven the model in MSK, we believe the opportunity ahead is far larger,"








